Tuesday, May 22, 2012 11:49:51 PM
IMDS(.0004), FDA stock, DD with links, MUST READ
1) IMDS, fully reporting OTCQB company
http://www.otcmarkets.com/stock/IMDS/company-info
2) Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM). As of June 30, 2010, IDSI was in the process of commercializing the CTLM in certain international markets where approvals to market have been secured although CTLM is not yet approved for sale in the United States. During the fiscal year ended June 30, 2010, the Company had no revenues from its operations. The CTLM system is a CT-like scanner, but its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. IDSI’s Laser Imager for Lab Animals (LILA) program is an optical helical micro-CT scanner in a third-generation configuration.
http://www.imds.com/
3) IMDS is a company with 28 patents
http://www.imds.com/ctlm/CTLM-Patents.php
http://www.patentstorm.us/search/advanced.html?ptn_no=&inv_nm=&ttl=&isdt_start=&isdt_end=&fldt_start=&fldt_end=&ptn_txt=&asg_nm=Imaging+Diagnostic+Systems%2C+Inc.&atn=&examiner=&cls=&int_cls=&doc_type%5B%5D=0&doc_type%5B%5D=1&sort=0
http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=IMDS:US
4) Watch Video: A Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM).
http://www.imds.com/imaging-diagnostics/IDSI-Video.php
5) IMDS distributors all over the world. 25 countries
http://www.imds.com/ctlm/CTLM-Distributors.php
6) IMDS- FDA Regulatory Status
As of November 2010, IDSI has submitted a 510(k) application to the FDA. With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system. The Company intends to pursue a rigorous clinical program to discover and commercialize the envisioned applications.
http://www.imds.com/ctlm/Regulatory-Status.php
7) The company has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO 13485 certification, China SFDA and FDA export certification, enabling sales in international markets.
http://www.imds.com/ctlm/Regulatory-Status.php
8) IMDS recently cancelled 740 million shares
it was 1.45 billion o/s. THE COMPANY CANCELED 740 MILLION SHARES.
SEC FILINGS OUT ON MAY 17, 2012
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8038247
200 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8163875
180 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8204806
180 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8272181
180 mil
http://ih.advfn.com/p.php?pid=nmona&article=52462072
http://ih.advfn.com/p.php?pid=nmona&article=52462084
http://ih.advfn.com/p.php?pid=nmona&article=52462089
http://ih.advfn.com/p.php?pid=nmona&article=52462100
http://www.otcmarkets.com/stock/IMDS/company-info
9) IMDS revenue increased 536% in March 2012 when you compare with March 31, 2011.
Revenue: 211,720 dollars, March 31, 2012
Revenue: 36,515 dollars, March 31, 2011
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8632452
~~~~~~~~~~~ MOST RECENT NEWS ~~~~~~~~~~~~~~
10) Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM(R) Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands
FORT LAUDERDALE, FL, May 14, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Shimadzu Medical to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Australia, New Zealand and the Pacific Islands.
"This strategic move follows in line with our vision to be in the forefront of innovative technologies that will further enhance our business. The Directors of Shimadzu Corporation unanimously agreed that the CTLM(R) system could heighten our image in the breast imaging realm. IDSI has developed a high quality innovative breast imaging product that will expand our product range. Shimadzu is well positioned to provide ongoing sales, service and support for the CTLM given our history and expertise in the medical device arena. We are excited to make this innovative technology available to women in Australia, New Zealand and the Pacific Islands," commented Nick Mascoulis, General Manager/Shimadzu Medical Systems (Oceania) P/L.
Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu's goal is to support a healthy, comfortable living for all people. They have strived to contribute to people's health and well-being since their inception in 1875. Shimadzu focuses on the development of "molecular imaging technology" to enable detection of subtle symptoms before the onset of full-blown diseases.
Linda Grable, CEO of Imaging Diagnostic Systems, Inc., states, "IDSI is very excited to appoint Shimadzu Corporation, a leader of global technologies, as the distributor in Australia, New Zealand and the Pacific Islands. We are eager to work with Shimadzu to make CTLM(R) available to women in that part of the globe."
11) Imaging Diagnostic's Non-Invasive CTLM(R) Laser Breast Imaging Device Will Soon Be Available to Women in Kuwait
FORT LAUDERDALE, FL, May 22, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. IMDS 0.00% , a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Mareen Group to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Kuwait.
"Mareen Group is honored to present the CTLM(R) to the women of Kuwait. We are eager to support the imaging needs of patients through this dignified and innovative laser breast imaging modality," commented Ahmad Abdulrahman, General Manager of Mareen Group.
Mareen Group is a Medical & Pharmaceutical distribution company well established and based in Kuwait. They have been in operation since 1998, proudly providing various medical and healthcare institutions within Kuwait and the surrounding areas with advanced medical equipment and pharmaceuticals from across the globe. The philosophy of Mareen Group has always been to build close ties with their customers by supporting their every need with prompt professional service and support.
Imaging Diagnostic's CEO, Linda Grable, states, "IDSI is delighted to assign Mareen Group, a well established medical company in Kuwait, as our new distributor. The women in Kuwait will hopefully benefit from CTLM(R)'s unique and discrete breast imaging process to aid in the diagnosis and management of breast abnormalities. We are enthusiastic to work with Mareen Group to make the CTLM(R), a non-invasive alternative, accessible to women in Kuwait."
IMDS is very undervalued solid company, Read, check the links..
WITH FDA PENDING NEWS THIS WILL GO UP MULTI-CENTS LEVEL, IMO.
~Blue~
1) IMDS, fully reporting OTCQB company
http://www.otcmarkets.com/stock/IMDS/company-info
2) Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM). As of June 30, 2010, IDSI was in the process of commercializing the CTLM in certain international markets where approvals to market have been secured although CTLM is not yet approved for sale in the United States. During the fiscal year ended June 30, 2010, the Company had no revenues from its operations. The CTLM system is a CT-like scanner, but its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. IDSI’s Laser Imager for Lab Animals (LILA) program is an optical helical micro-CT scanner in a third-generation configuration.
http://www.imds.com/
3) IMDS is a company with 28 patents
http://www.imds.com/ctlm/CTLM-Patents.php
http://www.patentstorm.us/search/advanced.html?ptn_no=&inv_nm=&ttl=&isdt_start=&isdt_end=&fldt_start=&fldt_end=&ptn_txt=&asg_nm=Imaging+Diagnostic+Systems%2C+Inc.&atn=&examiner=&cls=&int_cls=&doc_type%5B%5D=0&doc_type%5B%5D=1&sort=0
http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=IMDS:US
4) Watch Video: A Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM).
http://www.imds.com/imaging-diagnostics/IDSI-Video.php
5) IMDS distributors all over the world. 25 countries
http://www.imds.com/ctlm/CTLM-Distributors.php
6) IMDS- FDA Regulatory Status
As of November 2010, IDSI has submitted a 510(k) application to the FDA. With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system. The Company intends to pursue a rigorous clinical program to discover and commercialize the envisioned applications.
http://www.imds.com/ctlm/Regulatory-Status.php
7) The company has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO 13485 certification, China SFDA and FDA export certification, enabling sales in international markets.
http://www.imds.com/ctlm/Regulatory-Status.php
8) IMDS recently cancelled 740 million shares
it was 1.45 billion o/s. THE COMPANY CANCELED 740 MILLION SHARES.
SEC FILINGS OUT ON MAY 17, 2012
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8038247
200 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8163875
180 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8204806
180 mil
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8272181
180 mil
http://ih.advfn.com/p.php?pid=nmona&article=52462072
http://ih.advfn.com/p.php?pid=nmona&article=52462084
http://ih.advfn.com/p.php?pid=nmona&article=52462089
http://ih.advfn.com/p.php?pid=nmona&article=52462100
http://www.otcmarkets.com/stock/IMDS/company-info
9) IMDS revenue increased 536% in March 2012 when you compare with March 31, 2011.
Revenue: 211,720 dollars, March 31, 2012
Revenue: 36,515 dollars, March 31, 2011
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8632452
~~~~~~~~~~~ MOST RECENT NEWS ~~~~~~~~~~~~~~
10) Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM(R) Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands
FORT LAUDERDALE, FL, May 14, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Shimadzu Medical to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Australia, New Zealand and the Pacific Islands.
"This strategic move follows in line with our vision to be in the forefront of innovative technologies that will further enhance our business. The Directors of Shimadzu Corporation unanimously agreed that the CTLM(R) system could heighten our image in the breast imaging realm. IDSI has developed a high quality innovative breast imaging product that will expand our product range. Shimadzu is well positioned to provide ongoing sales, service and support for the CTLM given our history and expertise in the medical device arena. We are excited to make this innovative technology available to women in Australia, New Zealand and the Pacific Islands," commented Nick Mascoulis, General Manager/Shimadzu Medical Systems (Oceania) P/L.
Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu's goal is to support a healthy, comfortable living for all people. They have strived to contribute to people's health and well-being since their inception in 1875. Shimadzu focuses on the development of "molecular imaging technology" to enable detection of subtle symptoms before the onset of full-blown diseases.
Linda Grable, CEO of Imaging Diagnostic Systems, Inc., states, "IDSI is very excited to appoint Shimadzu Corporation, a leader of global technologies, as the distributor in Australia, New Zealand and the Pacific Islands. We are eager to work with Shimadzu to make CTLM(R) available to women in that part of the globe."
11) Imaging Diagnostic's Non-Invasive CTLM(R) Laser Breast Imaging Device Will Soon Be Available to Women in Kuwait
FORT LAUDERDALE, FL, May 22, 2012 (MARKETWIRE via COMTEX) -- Imaging Diagnostic Systems, Inc. IMDS 0.00% , a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Mareen Group to market and sell its Computed Tomography Laser Mammography (CTLM(R)) System in Kuwait.
"Mareen Group is honored to present the CTLM(R) to the women of Kuwait. We are eager to support the imaging needs of patients through this dignified and innovative laser breast imaging modality," commented Ahmad Abdulrahman, General Manager of Mareen Group.
Mareen Group is a Medical & Pharmaceutical distribution company well established and based in Kuwait. They have been in operation since 1998, proudly providing various medical and healthcare institutions within Kuwait and the surrounding areas with advanced medical equipment and pharmaceuticals from across the globe. The philosophy of Mareen Group has always been to build close ties with their customers by supporting their every need with prompt professional service and support.
Imaging Diagnostic's CEO, Linda Grable, states, "IDSI is delighted to assign Mareen Group, a well established medical company in Kuwait, as our new distributor. The women in Kuwait will hopefully benefit from CTLM(R)'s unique and discrete breast imaging process to aid in the diagnosis and management of breast abnormalities. We are enthusiastic to work with Mareen Group to make the CTLM(R), a non-invasive alternative, accessible to women in Kuwait."
IMDS is very undervalued solid company, Read, check the links..
WITH FDA PENDING NEWS THIS WILL GO UP MULTI-CENTS LEVEL, IMO.
~Blue~
follow me on THE BLUE EXCHANGE
Where Real Traders Talk Markets
Join thousands of traders sharing insights, catalysts, and charts.
